WHITE report FALLOUT The fight to keep COCKTAILS TO-GO CORREIA: ‘I will be vindicated’
05/17/2021 07:28 AM EDT
SHAKEN, NOW STIRRING That margarita delivered to your doorstep with dinner is destined to go away when the pandemic state of emergency ends unless a group of restaurant and business advocates gets their way.
Restaurateurs and business groups are planning a virtual rally today to push for a two-year extension of legislation authorizing cocktails to-go and capping third-party delivery-app fees at 15%. The original bill was opposed by package stores last year.
They also want a grant program for businesses that opened in 2020 and have struggled to access state and federal aid, and to compel insurance companies to pay business interruption claims. State Sen. Diana DiZoglio, who s co-hosting today s event, has filed all four as Senate budget amendments.
Article content
Vancouver, British Columbia–(Newsfile Corp. – April 30, 2021) – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) (“
Veritas” or the “
Company“) is pleased to announce the results of its Annual and Special Meeting of the Shareholders (the “
Meeting“) held on April 29
th, 2021. At the Meeting, shareholders approved the acquisition of Indigenous Bloom Hemp Corporation (“
HempCo“) by special resolution. Details of the acquisition are in the Company’s Information Circular dated March 1, 2021, the amendment thereto dated March 24, 2021 and in the Company’s news release dated September 9, 2020. The acquisition also received minority approval of shareholders pursuant to the provisions of Multilateral Instrument 61-101
Vancouver, British Columbia (Newsfile Corp. - April 30, 2021) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce the results of its Annual and
The Food and Drug Administration has authorized emergency use of the Moderna COVID-19 vaccine. That makes the vaccine developed by the Cambridge pharmaceutical company the second vaccine alongside the Pfizer vaccine to join the fight against the coronavirus pandemic.
Doctor Paul Sax, the clinical director of division of infectious diseases at Brigham and Women s Hospital, joined WBUR s Sharon Brody to discuss the the new Moderna vaccine, its approval, and how it differs from the Pfizer vaccine.
This segment aired on December 19, 2020.